Nomura Asset Management CO LTD Novavax Inc Transaction History

Nomura Asset Management CO LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$36.28 - $75.29 $507,557 - $1.05 Million	-13,990 Closed	0 $0
Q1 2022 Jan 10, 2025	BUY	$69.73 - $142.9 $975,522 - $2 Million	13,990 New	13,990 $1.03 Million
Q4 2021 Jan 10, 2025	BUY	$134.56 - $217.97 $148,016 - $239,767	1,100 Added 8.53%	13,990 $2 Million
Q4 2021 Feb 01, 2022	BUY	$134.56 - $217.97 $148,016 - $239,767	1,100 Added 8.53%	13,990 $2 Million
Q2 2021 Jan 10, 2025	BUY	$121.0 - $257.67 $1.56 Million - $3.32 Million	12,890 New	12,890 $2.74 Million
Q2 2021 Aug 06, 2021	BUY	$121.0 - $257.67 $1.56 Million - $3.32 Million	12,890 New	12,890 $2.74 Million
Q1 2021 Jan 10, 2025	BUY	$112.98 - $319.93 $0 - $0	0 New	0 $0
Q1 2021 May 14, 2021	BUY	$112.98 - $319.93 $0 - $0	0 New	0 $0
Q4 2020 Jan 10, 2025	BUY	$78.74 - $139.5 $0 - $0	0 New	0 $0
Q4 2020 Feb 12, 2021	BUY	$78.74 - $139.5 $0 - $0	0 New	0 $0
Q3 2020 Nov 12, 2020	BUY	$79.44 - $178.51 $0 - $0	0 New	0 $0

285

93.8M

5.4M

8.76M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $640M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.